Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease. Biomedical Research and Therapy, [S. l.], v. 6, n. 7, p. 3262–3273, 2019. DOI: 10.15419/bmrat.v6i7.553. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/553.. Acesso em: 15 nov. 2024.